Baloxavir (API & Research Grade)

Innovative Anti-Influenza Agent for Source-Level Replication Blocking

SAFETY DECLARATION:

This product is intended for Industrial Use or Scientific Research only. It is not approved for direct human consumption or clinical diagnostic procedures. Shaanxi Sunrise Pharmaceutical provides high-purity raw materials for pharmaceutical R&D.

Product Overview

Shaanxi Sunrise provides high-purity Baloxavir raw materials that strictly adhere to international pharmaceutical standards. Our synthesis process utilizes precise multi-level quality control, ensuring that key impurities are significantly lower than pharmacopoeia limits.

As the active metabolite of Baloxavir Marboxil (Xofluza), Baloxavir offers a revolutionary mechanism of action by targeting the very early stages of viral mRNA synthesis, achieving "source blocking" of influenza A and B viruses.

Mechanism of Action

CEN Inhibition Strategy

Unlike neuraminidase inhibitors (like Oseltamivir) which prevent the release of newly formed viruses, Baloxavir acts deeper:

Target: Specifically inhibits the "Cap-dependent Endonuclease" (CEN) within the virus.
Action: Blocks the transcription of viral mRNA, effectively halting the replication of the viral genome.
Speed: Clinical data confirms a significant reduction in viral load within 24 hours of a single dose.

Comparative Advantage

A strategic comparison between Baloxavir and traditional treatments:

Characteristics	Baloxavir (Sunrise Quality)	Oseltamivir (Traditional)
Mechanism	Endonuclease Inhibitor	Neuraminidase Inhibitor
Regimen	Single Oral Dose	10 Doses (5 Days)
Effective Time	< 24 Hours	24-48 Hours
Half-life	79-125 Hours	6-10 Hours

Key Applications

API Manufacturing: Ideal for the production of oral tablets or liquid suspensions.
Broad-Spectrum Research: Effective against Influenza A (H1N1, H3N2, H5N1, H7N9) and Influenza B.
High-Risk R&D: Developing treatments for elderly or chronic disease patients with influenza complications.

Global Supply & Reliability

By choosing Shaanxi Sunrise Pharmaceutical, you secure a partner dedicated to purity and supply chain stability. Our Baloxavir API is optimized for high patient compliance and long-lasting efficacy.